Coherus market cap

Author: psvb

August undefined, 2024

WebAug 19, 2024 · Coherus’ market cap is US$1 billion, the forward P/E one year is -4.46, the EPS is US$-2.32, and the 52-week highest and the lowest stock price of the company was US$22.22 and US$12.21. The stock fell 18.64 percent YTD. Also read: Check out these fastest-growing small-cap healthcare stocks WebFeb 28, 2024 · The Investor Relations website contains information about Coherus BioSciences, Inc.'s business for stockholders, potential investors, and financial ...

Coherus: Biosimilar Specialist With Approval Shot For Cancer Drug ...

WebFeb 28, 2024 · Biweekly Failures to deliver volume for Coherus BioSciences (CHRS) - since 2014 Volume in USD (price x number of shares), data since 2014 2016 2024 2024 $5M $10M $15M 0 companiesmarketcap.com Coherus BioSciences (CHRS) Failure to deliver volume, Year over Year FTD volume in the last 3 months for similar companies or … Web18 hours ago · The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator ... イエローバックス顎下

Coherus BioSciences, Inc. (CHRS) Stock Price Today, Quote & News

WebApr 6, 2024 · Sentiment All Sentiments. Source. Headline. Coherus BioSciences (NASDAQ:CHRS) Coverage Initiated by Analysts at StockNews.com. americanbankingnews.com - March 20 at 7:20 AM. Coherus BioSciences (NASDAQ:CHRS) Price Target Raised to $23.00. americanbankingnews.com - March 17 … WebCoherus Biosciences Stock Price Today (NASDAQ: CHRS) Quote, Market Cap, Chart WallStreetZen Coherus Biosciences Inc Stock Add to Watchlist Overview Forecast … WebMar 24, 2024 · With the market capitalization of Coherus BioSciences Inc. currently standing at about $492.06 million, investors are eagerly awaiting this quarter’s results, scheduled for May 03, 2024 – May 08, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. … イエロー-ハット

CHRS Price Target 2024 Coherus BioSciences Analyst Ratings

Coherus BioSciences (CHRS) - Failure to deliver history

WebAs of April 2024 Coherus BioSciences has a market cap of $0.59 Billion. This makes Coherus BioSciences the world's 5195th most valuable company by market cap according to our data. The market capitalization, … WebMarket Cap. Historical daily share price chart and data for Coherus BioSciences since 2024 adjusted for splits. The latest closing stock price for Coherus BioSciences as of March … otp digitalWebMar 6, 2024 · Coherus BioSciences, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $45.35 million for the quarter ended December 2024, missing the Zacks Consensus... イエローバックス耳

"WebApr 12, 2024 · Coherus BioSciences (NASDAQ:CHRS – Get Rating) and Sutro Biopharma (NASDAQ:STRO – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and … " - Coherus market cap

Coherus market cap

Coherus: Launch Of Humira Biosimilar May Boost Stock

WebDec 7, 2024 · According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Rubric Capital Management, managed by David Rosen, holds the largest position in...

Did you know?

WebApr 11, 2024 · Coherus BioSciences, Inc. was incorporated in 2010 and is headquartered in Redwood City, California. More... Sector Health Care Industry Biotechnology Employees 359 Founded 2010 Address 333 Twin... WebMar 17, 2024 · See the latest Coherus BioSciences Inc stock price (NASDAQ:CHRS), related news, valuation, dividends and more to help you make your investing decisions.

WebApr 9, 2024 · The company has a market capitalization of $609.81 million, a PE ratio of -2.04 and a beta of 0.95. Coherus BioSciences, Inc. has a 52-week low of $5.58 and a 52-week high of $14.11. WebMar 30, 2024 · Market Cap Chart Since November 6, 2014, Coherus BioSciences, Inc.'s market cap has increased from $103.23M to $513.48M, an increase of 397.41%. That is …

WebCoherus BioSciences market cap history and chart from 2013 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the … WebJul 23, 2024 · Coherus Bio Market Capitalization is currently at 585.1 M. Market Capitalization is the total market value of Coherus Bio's equity. It is one of many ways …

WebCurrent and historical earnings charts for Coherus BioSciences . As of April 2024 Coherus BioSciences 's TTM earnings are -$0.26 B. companies: 7,323 total market cap: $86.813 T. ... The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company. In most cases it can be easily calculated by multiplying the ...

WebMay 27, 2024 · CHRS has a market cap of $593mn and a cash balance of $325mn. Net revenue was $60.1 million and $83.0 million during the three months ended March 31, 2024 and 2024, respectively. The revenue... イェローバックス顔WebApr 12, 2024 · According to analysts' consensus price target of $16.50, Coherus BioSciences has a forecasted upside of 120.9% from its current price of $7.47. Amount of Analyst Coverage Coherus BioSciences has … otp device definitionWebFind real-time CHRS - Coherus BioSciences Inc stock quotes, company profile, news and forecasts from CNN Business. CHRS - Coherus BioSciences Inc Stock quote - … イエローハットWebApr 10, 2024 · Coherus BioSciences has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Comparatively, Sutro Biopharma has a beta of 0.89, suggesting that its stock price is ... イエローハットWebJan 3, 2024 · On December 30, 2024, Coherus BioSciences, Inc. (NASDAQ:CHRS) stock closed at $7.92 per share. One-month return of Coherus BioSciences, Inc. (NASDAQ:CHRS) was 17.51%, and its shares lost 51.74%... otp ddicWebMar 28, 2024 · On Friday 03/10/2024 the closing price of the Coherus BioSciences Inc share was $6.07 on NAS. Compared to the opening price on Friday 03/10/2024 on NAS of $6.25, this is a drop of 2.97%. Coherus ... otp direkt utalási limitWebMar 6, 2024 · Coherus BioSciences, Inc. provided earnings guidance for the year 2024 and 2024. For the year, the company expects significant topline revenue growth. ... Capitalization: 621 M 621 M-EV / Sales 2024: 3,12x: EV / Sales 2024: 1,61x: Nbr of Employees: 359: Free-Float: 89,9%: More Financials. otp data retention